The Future is Now: Cryo-EM and AI Empowering Drug Innovation at Shuimu BioSciences
In the rapidly evolving landscape of drug discovery, Shuimu BioSciences (ShuimuBio) stands at the forefront, harnessing the power of cryo-electron microscopy (cryo-EM) and artificial intelligence (AI) to unlock new frontiers in drug innovation. As a global leader in structural biology and drug discovery, ShuimuBio is pioneering the integration of these cutting-edge technologies, revolutionizing the development of novel therapeutics, particularly in the realm of G-protein coupled receptors (GPCRs).
Cryo-EM: Unveiling the Structural Secrets of GPCRs GPCRs, a vast and largely untapped family of membrane proteins, have long been considered challenging targets for drug development due to their dynamic nature and inherent structural complexity. However, the advent of cryo-EM has opened new doors, enabling researchers to visualize these intricate protein structures at an unprecedented level...